In a move aimed to promote research and development (R&D) across the pharmaceutical and medical technology sectors, the Union Health Ministry has allocated Rs. 5,000 crore for a period of five years. The allocated fund aims to push for research across the private sector by setting up incubation centres. The Promotion of Research and Innovation […]
The Global Fund invests over US$4 billion per year to fight infectious diseases in 120 countries. We believe there is a significant opportunity for India’s pharmaceutical industry and other private-sector companies to take a leading role in the global fight to end deadly communicable diseases. India is setting a remarkable precedent in global health leadership
Dr Damodharan M, Chief Quality Officer, Global Quality & Regulatory Affairs, Sai Life Sciences Limited, and Dr Sujay Rajhans, President, R&D, JB Pharma, in a fireside chat with Vikas Dandekar, Editor, Pharma & Healthcare, ETPrime, shared how digitalisation can reduce CAPEX, improve efficiency and productivity. They discussed the need for IT in QA and how
